These findings were strengthened through in vivo experiments, which demonstrated that absence of SHP-1 increased NK cell activity and decreased tumor progression, irrespective of PKC-θ expression, implying that PKC-θ indeed maintains NK cell activation through its regulation of SHP-1. This evidence concerns the gene PRRT2 and neoplasm.